Skip to content

Clinical trials

Schizophrenia trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: Netherlands Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20042
20051
20062
20072
20082
20091
20103
20112
20121
20131
20141
20151
20162
20171
20191
20211
20221
20244
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Recruiting3
Not yet recruiting2
Terminated2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UMC Utrecht5
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)4
AstraZeneca3
University Medical Center Groningen3
Boehringer Ingelheim2
Eli Lilly and Company2
Hoffmann-La Roche2
Iris Sommer2
Janssen-Cilag International NV2
Otsuka Pharmaceutical Development & Commercialization, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia37
Psychotic Disorders15
Bipolar Disorder4
Mental Disorders4
Mania2
Anhedonia1
Autistic Disorder1
Bipolar and Related Disorders1
Cognitive Dysfunction1
Hallucinations1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.